Axcelis Technologies, Inc. — Q3 2022 Form 10-Q
Business context and reporting period. Axcelis makes ion implantation equipment for semiconductor manufacturing and provides related aftermarket products and services. This unaudited quarterly report covers the three and nine months ended September 30, 2022; comparisons are with the same 2021 periods. Unless noted otherwise, financial figures below are in U.S. dollars.
Financial performance and position
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Revenue | $229.2 million | $176.7 million | $653.9 million | $456.7 million |
| Gross profit / margin | $103.3 million / 45.1% | $76.5 million / 43.3% | $292.3 million / 44.7% | $197.0 million / 43.1% |
| Operating income / margin | $53.2 million / 23.2% | $36.4 million / 20.6% | $156.3 million / 23.9% | $80.7 million / 17.7% |
| Net income | $40.3 million | $27.5 million | $126.1 million | $62.9 million |
| Diluted EPS | $1.21 | $0.81 | $3.75 | $1.83 |
- Revenue increased 29.7% in Q3 and 43.2% year to date. Growth was primarily driven by higher system sales. Q3 systems revenue was $171.1 million, versus $126.2 million; aftermarket revenue was $58.1 million, versus $50.5 million.
- Gross margin improved, which management attributed mainly to improved Purion system margins and, for services, a more favorable mix of service contracts. Operating expenses rose 24.9% in Q3 and 17.0% year to date, but declined as a share of revenue.
- Other expense was $8.2 million in Q3 and $17.2 million year to date, substantially higher than the prior-year periods, primarily because of increased foreign-exchange losses.
- Cash flow: Nine-month operating cash flow was $93.2 million, down from $112.1 million. Working-capital uses included $77.4 million from accounts receivable and $49.7 million from inventory; higher deferred revenue provided $54.8 million. Capital expenditures were $6.9 million. Cash used for share repurchases was $45.0 million.
- Liquidity: At September 30, 2022, cash and cash equivalents were $308.6 million, short-term investments $33.6 million, and restricted cash $0.8 million. Current assets were $775.1 million and current liabilities $207.9 million.
- Debt and leases: The company reported $46.7 million of finance lease obligations and $11.9 million of operating lease obligations. Its $40 million revolving credit facility had no borrowings; a $5.9 million letter of credit reduces availability. Axcelis reported compliance with its covenants.
Material changes versus prior periods
- For the first nine months, revenue rose 43.2% and net income approximately doubled year over year, while operating cash flow declined. Accounts receivable increased to $173.9 million from $104.4 million at year-end 2021, and inventory increased to $226.5 million from $195.0 million.
- Systems revenue reached $488.2 million for the nine months, up from $307.3 million. Aftermarket revenue increased to $165.7 million from $149.4 million.
- Deferred revenue rose to $122.6 million from $68.4 million at year-end, reflecting advance payments and future performance obligations associated with system sales.
- Axcelis repurchased 0.7 million shares during the first nine months at an average cost of $64.85 per share, under a $100 million program authorized in February 2022. Approximately $55.0 million remained available at September 30.
Outlook, commentary, and risks
- Management described continued strong semiconductor and capital-equipment demand alongside ongoing supply-chain challenges. It reported that 84% of shipments in the first nine months went to mature foundry/logic customers. The filing provides no specific revenue or earnings guidance.
- Management said current cash, cash equivalents, and financing capacity should be sufficient for anticipated short- and long-term cash requirements. It also cited the cash needs of business growth, repurchases, and potential organic or inorganic growth opportunities.
- Customer concentration remains significant: the ten largest customers generated 60.7% of nine-month revenue; one customer represented 14.8% of that revenue and 13.2% of period-end receivables.
- Risks include customer capital-spending and fab-utilization fluctuations, semiconductor-industry and global economic conditions, supply-chain constraints, foreign-exchange movements, and reliance on a concentrated customer base. On October 7, 2022, the U.S. Department of Commerce issued regulations affecting sales of U.S. goods to China and sourcing from China; Axcelis was assessing the impact and did not then anticipate a material effect.
- The company reported no litigation it believes could materially adversely affect operations, no material changes to its previously disclosed risk factors, and no significant off-balance-sheet hedging arrangements. Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting.
- An executive transition was disclosed: EVP of Product Development William Bintz was to resign as an executive officer effective December 31, 2022, in connection with retirement; Greg Redinbo had assumed the EVP, Marketing and Applications title.
Important facts for investors to verify
- Whether strong system demand and improved product margins persist, especially given the company’s concentration in mature-process customers and customer capital-spending cycles.
- Whether elevated receivables and inventory convert to cash, and whether working-capital demands continue to constrain operating cash flow.
- The amount and drivers of foreign-exchange losses, and exposure to currency movements and evolving China-related export and sourcing rules.
- Customer concentration, deferred-revenue obligations, and the remaining availability and July 2023 expiry of the revolving credit facility.
- Execution and cash requirements for the share-repurchase program and any growth opportunities; the filing provides no quantitative forward guidance.